Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.3300
0.00 (0.00%)
At close: Aug 7, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 45.25 million as of August 7, 2026. Its market cap has decreased by -7.34% in one year.
Market Cap
45.25M
Enterprise Value
35.82M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
ChartMarket Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 45.25M, an increase of 76.06%. That is a compound annual growth rate of 20.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 45.25M | -45.35% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 92.01M |
| Cyclopharm | 68.71M |
| Epiminder | 68.15M |
| Compumedics | 46.94M |
| Nova Eye Medical | 41.30M |
| HeraMED | 39.35M |
| OncoSil Medical | 38.92M |
| CleanSpace Holdings | 32.35M |